SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-184922
Filing Date
2019-06-28
Accepted
2019-06-28 06:06:03
Documents
6
Period of Report
2019-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d749614d8k.htm 8-K 21787
2 EX-5.1 d749614dex51.htm EX-5.1 7797
3 EX-10.1 d749614dex101.htm EX-10.1 176349
4 EX-99.1 d749614dex991.htm EX-99.1 7550
5 GRAPHIC g749614g0628045350004.jpg GRAPHIC 2744
6 GRAPHIC g749614g0628045723259.jpg GRAPHIC 3311
  Complete submission text file 0001193125-19-184922.txt   223313
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 19927222
SIC: 2836 Biological Products, (No Diagnostic Substances)